INanoBio presenting at PMWC

INanoBio CEO,  Bharath Takulapalli will be presenting at the Precision Medicine World Conference 2022 at the Santa Clara Convention Center.

INanoBio at MSTC 2022

INanoBio CEO, Bharath Takulapalli to speak at the MEMS & Sensors Technical Congress to be held at the David Brower Center in Berkeley.

Genomeweb Coverage of FENT Prototype Development

Nanopore Sequencing Firm iNanoBio Says Fast Sensor Will Result in Speedy Platform

FENT Prototype Development

INanoBio Announces Successful Development of Novel Nanopore Transistor Prototype, a Step Towards Ultra-Fast DNA Sequencing

Genomeweb on DARPA ECHO Award

INanoBio Nabs $5.4M From DARPA for Silicon Nanopore Sequencer Development

DARPA ECHO PROGRAM

INanoBio awarded up to $5.4 Million to develop an Epigenetic Sequencer under the DARPA ECHO Program.

INanoBio Expands Board

Dr. Abhay Sanan and JP Million join INanoBio Board of Directors as part of 2018 Series Seed financing

NIH SBIR GRANT

INanoBio awarded $0.7 M grant by National Institute of Health (NIH) to develop an advanced automated system for high throughput proteomic assays.

IEEE VLSI TSA Keynote

INanoBio CEO Bharath Takulapalli to Keynote IEEE VLSI TSA conference in Taiwan.

Nature.com Webcast

INanoBio participates in Nature.com webcast on ‘Advances in Precision Medicine and Genomic Sequencing’.